CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PDL BioPharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PDL BioPharma Inc
59 Damonte Ranch Parkway, Suite B-375
Phone: (775) 832-8500p:775 832-8500 RENO, NV  89521  United States Fax: (775) 832-8501f:775 832-8501
This company ceased filing statements with the SEC on 1/8/2021.
Business Summary
PDL BioPharma Inc is a United States-based company, which is a portfolio of income producing assets based on alternative financing. The Company investments generally involve assets with intellectual property protection and are at the commercial stage or about to be approved. The Company’s business, paying and making provision to pay its creditors and distributing the proceeds of its liquidation process to its stockholders pursuant to the Plan of Dissolution.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2020YesYes--Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairperson of the Board ElizabethO'farrell 1/1/2020 6/22/2018
Chief Executive Officer, General Counsel, Company Secretary, Director ChristopherStone 1/1/2021 2/1/2009
Chief Financial Officer ChristyHorgan
Director John P.Mclaughlin 71 12/31/2018 10/8/2008
Director DominiqueMonnet 1/1/2019 9/11/2017

Business Names
Business Name
Depo Sub Manager, LLC
DFM, LLC
PDL Investment Holdings, LLC
PDLI

General Information
Number of Employees: 75 (As of 12/31/2019)
Outstanding Shares: 114,111,358 (As of 12/31/2022)
Shareholders: 120
Stock Exchange: NASD
Federal Tax Id: 943023969
Fax Number: (775) 832-8501
Email Address: cc@pdl.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024